Imatinib GIST-Teva 100 mg
Imatinib GIST-Teva 100 mg is a medicine authorised by Swissmedic under authorisation number 66621. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 July 2017 and the authorisation is valid without a time limit. ATC code L01EA01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 66621 |
|---|---|
| Name | Imatinib GIST-Teva 100 mg |
| Full name | Imatinib GIST-Teva 100 mg, Filmtabletten |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA01 |
| First authorisation | 10 July 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Imatinib GIST-Teva 100 mg, Filmtabletten | A | 10 July 2017 |
| 2 | Imatinib GIST-Teva 400 mg, Filmtabletten | A | 10 July 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01EA01 | 07.16.1. | A |
| 2 | 30 | Tablette(n) | L01EA01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Imatinib GIST-Teva 100 mg authorised in Switzerland?
Yes. Imatinib GIST-Teva 100 mg is authorised by Swissmedic under authorisation number 66621, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Imatinib GIST-Teva 100 mg have?
Imatinib GIST-Teva 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Imatinib GIST-Teva 100 mg?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.